SURG vs. CXDO, NXPL, ISIG, ATTOF, ORAN, TLK, TEO, TIMB, VZ, and T
Should you be buying SurgePays stock or one of its competitors? The main competitors of SurgePays include Crexendo (CXDO), NextPlat (NXPL), Insignia Systems (ISIG), Atento (ATTOF), Orange (ORAN), Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (TLK), Telecom Argentina (TEO), TIM (TIMB), Verizon Communications (VZ), and AT&T (T).
Crexendo (NASDAQ:CXDO) and SurgePays (NASDAQ:SURG) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.
Crexendo currently has a consensus target price of $6.38, indicating a potential upside of 96.15%. SurgePays has a consensus target price of $10.00, indicating a potential upside of 173.22%. Given Crexendo's higher probable upside, analysts clearly believe SurgePays is more favorable than Crexendo.
9.5% of Crexendo shares are owned by institutional investors. Comparatively, 6.9% of SurgePays shares are owned by institutional investors. 56.6% of Crexendo shares are owned by company insiders. Comparatively, 29.4% of SurgePays shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Crexendo has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. Comparatively, SurgePays has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500.
In the previous week, Crexendo had 1 more articles in the media than SurgePays. MarketBeat recorded 2 mentions for Crexendo and 1 mentions for SurgePays. Crexendo's average media sentiment score of 1.89 beat SurgePays' score of 1.43 indicating that SurgePays is being referred to more favorably in the news media.
SurgePays has a net margin of 12.93% compared to SurgePays' net margin of 3.01%. Crexendo's return on equity of 55.35% beat SurgePays' return on equity.
SurgePays has higher revenue and earnings than Crexendo. SurgePays is trading at a lower price-to-earnings ratio than Crexendo, indicating that it is currently the more affordable of the two stocks.
SurgePays received 157 more outperform votes than Crexendo when rated by MarketBeat users. Likewise, 68.72% of users gave SurgePays an outperform vote while only 38.46% of users gave Crexendo an outperform vote.
Summary
SurgePays beats Crexendo on 10 of the 18 factors compared between the two stocks.
Get SurgePays News Delivered to You Automatically
Sign up to receive the latest news and ratings for SURG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SURG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SurgePays Competitors List
Related Companies and Tools
